Divi’s Laboratories Investor Relations Material
Latest events
Q4 24/25
Divi’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Divi’s Laboratories Limited
Access all reports
Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global pharmaceutical companies. The company specializes in custom synthesis and contract manufacturing for generic and branded drugs. Divi’s Laboratories serves customers in regulated markets including the United States and Europe. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DIVISLAB
Country
🇮🇳 India